Tada H, Takanashi J, Barkovich A, et al. Clinically mild encephalitis/encephalopathy with a reversible splenial lesion. Neurology. 2004;63:1854–8.
Article
CAS
PubMed
Google Scholar
Garcia-Monco JC, Cortina IE, Ferreira E, et al. Reversible splenial lesion syndrome (RESLES): what's in a name? J Neuroimaging. 2011;21:e1–e14.
Article
PubMed
Google Scholar
Takanashi J-i. Two newly proposed infectious encephalitis/encephalopathy syndromes. Brain Dev. 2009;31:521–8.
Takanashi J, Barkovich A, Shiihara T, et al. Widening spectrum of a reversible splenial lesion with transiently reduced diffusion. Am J Neuroradiol. 2006;27:836–8.
CAS
PubMed
Google Scholar
Notebaert A, Willems J, Coucke L, Van Coster R, Verhelst H. Expanding the spectrum of MERS type 2 lesions, a particular form of encephalitis. Pediatr Neurol. 2013;48:135–8.
Article
PubMed
Google Scholar
Cho J-S, Ha S-W, Han Y-S, et al. Mild encephalopathy with reversible lesion in the splenium of the corpus callosum and bilateral frontal white matter. J Clin Neurol. 2007;3:53–6.
Article
PubMed
PubMed Central
Google Scholar
Takanashi J-i, Barkovich AJ, Yamaguchi K-i, Kohno Y. Influenza-associated encephalitis/encephalopathy with a reversible lesion in the splenium of the corpus callosum: a case report and literature review. Am J Neuroradiol. 2004;25:798–802.
Fuchigami T, Goto K, Hasegawa M, et al. A 4-year-old girl with clinically mild encephalopathy with a reversible splenial lesion associated with rotavirus infection. J Infect Chemother. 2013;19:149–53.
Article
PubMed
Google Scholar
Takanashi J-i, Shiihara T, Hasegawa T, et al. Clinically mild encephalitis with a reversible splenial lesion (MERS) after mumps vaccination. J Neurol Sci. 2015;349:226–8.
Article
Google Scholar
Shibuya H, Osamura K, Hara K, Hisada T. Clinically mild encephalitis/encephalopathy with a reversible splenial lesion due to Mycoplasma pneumoniae infection. Intern Med. 2012;51:1647–8.
Article
PubMed
Google Scholar
Tomizawa Y, Hoshino Y, Sasaki F, et al. Diagnostic utility of Splenial lesions in a case of Legionnaires’ disease due to Legionella pneumophila Serogroup 2. Intern Med. 2015;54:3079–82.
Article
CAS
PubMed
Google Scholar
Kim SS, Chang K-H, Kim ST, et al. Focal lesion in the splenium of the corpus callosum in epileptic patients: antiepileptic drug toxicity? Am J Neuroradiol. 1999;20:125–9.
CAS
PubMed
Google Scholar
Polster T, Hoppe M, Ebner A. Transient lesion in the splenium of the corpus callosum: three further cases in epileptic patients and a pathophysiological hypothesis. J Neurol Neurosurg Psychiatry. 2001;70:459–63.
Article
CAS
PubMed
PubMed Central
Google Scholar
Maeda M, Shiroyama T, Tsukahara H, Shimono T, Aoki S, Takeda K. Transient splenial lesion of the corpus callosum associated with antiepileptic drugs: evaluation by diffusion-weighted MR imaging. Eur Radiol. 2003;13:1902–6.
Article
PubMed
Google Scholar
Karampatsas K, Spyridou C, Morrison IR, Tong CY, Prendergast AJ. Rotavirus-associated mild encephalopathy with a reversible splenial lesion (MERS)—case report and review of the literature. BMC Infect Dis. 2015;15:1.
Article
Google Scholar
Barkovich AJ. Pediatric neuroimaging: Lippincott Williams & Wilkins, 2005.
Google Scholar
Miyata R, Tanuma N, Hayashi M, et al. Oxidative stress in patients with clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS). Brain Dev. 2012;34:124–7.
Article
PubMed
Google Scholar
Takanashi J-i, Maeda M, Hayashi M. Neonate showing reversible splenial lesion. Arch Neurol. 2005;62:1481–2.
Article
Google Scholar
Engelbrecht V, Scherer A, Rassek M, Witsack HJ, Mödder U. Diffusion-weighted MR imaging in the brain in children: findings in the normal brain and in the brain with white matter diseases 1. Radiology. 2002;222:410–8.
Article
PubMed
Google Scholar
Phillips MD, McGraw P, Lowe MJ, Mathews VP, Hainline BE. Diffusion-weighted imaging of white matter abnormalities in patients with phenylketonuria. Am J Neuroradiol. 2001;22:1583–6.
CAS
PubMed
Google Scholar
Takanashi J-i, Tada H, Maeda M, Suzuki M, Terada H, Barkovich AJ. Encephalopathy with a reversible splenial lesion is associated with hyponatremia. Brain Dev. 2009;31:217–20.
Takanashi J-i, Hirasawa K-i, Tada H. Reversible restricted diffusion of entire corpus callosum. J Neurol Sci. 2006;247:101–4.
Hong JM, Park MS, Jun D. Transient splenial lesion of the corpus callosum in patients with infectious disease. J Korean Neurol Assoc. 2005;23:667–70.
Google Scholar
Dyken PR. Viral diseases of the nervous system. Pediatr Neurol. 1994;1:499–501.
Google Scholar
Friese S, Bitzer M, Freudenstein D, Voigt K, Küker W. Classification of acquired lesions of the corpus callosum with MRI. Neuroradiology. 2000;42:795–802.
Article
CAS
PubMed
Google Scholar
Mizuguchi M, Yamanouchi H, Ichiyama T, Shiomi M. Acute encephalopathy associated with influenza and other viral infections. Acta Neurol Scand. 2007;115:45–56.
Article
CAS
PubMed
Google Scholar
Tascilar N, Aydemir H, Emre U, Unal A, Atasoy HT, Ekem S. Unusual combination of reversible splenial lesion and meningitis-retention syndrome in aseptic meningomyelitis. Clinics. 2009;64:932–7.
Article
PubMed
PubMed Central
Google Scholar
Kitami M, Kubo S-i, Nakamura S, Shiozawa S, Isobe H, Furukawa Y. Acute urinary retention in a 23-year-old woman with mild encephalopathy with a reversible splenial lesion: a case report. J Med Case Rep. 2011;5:159.
Article
PubMed
PubMed Central
Google Scholar
Vollmann H, Hagemann G, Mentzel H-J, Witte OW, Redecker C. Isolated reversible splenial lesion in tick-borne encephalitis: a case report and literature review. Clin Neurol Neurosurg. 2011;113:430–3.
Article
PubMed
Google Scholar
Renard D, Taieb G, Briere C, Bengler C, Castelnovo G. Mild encephalitis/encephalopathy with a reversible splenial, white matter, putaminal, and thalamic lesions following anti-Yo rhombencephalitis. Acta Neurol Belg. 2012;112:405-7.
Mitaki S, Onoda K, Ishihara M, Nabika Y, Yamaguchi S. Dysfunction of default-mode network in encephalopathy with a reversible corpus callosum lesion. J Neurol Sci. 2012;317:154–6.
Article
PubMed
Google Scholar
Shankar B, Narayanan R, Muralitharan P, Ulaganathan B. Evaluation of mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) by diffusion-weighted and diffusion tensor imaging. BMJ case reports. 2014;2014:bcr2014204078.
Article
PubMed
PubMed Central
Google Scholar
Ko SY, Kim BK, Kim DW, et al. Reversible splenial lesion on the corpus callosum in nonfulminant hepatitis a presenting as encephalopathy. Clin Mol Hepatol. 2014;20:398–401.
Article
PubMed
PubMed Central
Google Scholar
Hibino M, Horiuchi S, Okubo Y, Kakutani T, Ohe M, Kondo T. Transient Hemiparesis and Hemianesthesia in an atypical case of adult-onset clinically mild encephalitis/encephalopathy with a reversible Splenial lesion associated with adenovirus infection. Intern Med. 2014;53:1183–5.
Article
PubMed
Google Scholar
Conry RM, Sullivan JC, Nabors LB. Ipilimumab-induced encephalopathy with a reversible splenial lesion. Cancer Immunol Res. 2015;3:598–601.
Article
PubMed
Google Scholar
Pan JJ, Zhao Y-y, Lu C, Hu YH, Yang Y. Mild encephalitis/encephalopathy with a reversible splenial lesion: five cases and a literature review. Neurol Sci. 2015;36:2043–51.
Zhang S, Ma Y, Feng J. Clinicoradiological spectrum of reversible splenial lesion syndrome (RESLES) in adults: a retrospective study of a rare entity. Med. 2015;94(6):e512.
Degirmenci E, Degirmenci T, Cetin EN, Kıroğlu Y. Mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) in a patient presenting with papilledema. Acta Neurol Belg. 2015;115:153–5.
Article
PubMed
Google Scholar
Alakbarova N, Eraslan C, Celebisoy N, Karasoy H, Gonul AS. Mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) development after Amanita phalloides intoxication. Acta Neurol Belg. 2015:1–3.
Gawlitza M, Hoffmann KT, Lobsien D. Mild encephalitis/encephalopathy with reversible Splenial and Cerebellar lesions (MERS type II) in a patient with hemolytic uremic syndrome (HUS). J Neuroimaging. 2015;25:145–6.
Article
PubMed
Google Scholar